CCT128930 – 5 mg

Brand:
Cayman
CAS:
885499-61-6
Storage:
-20
UN-No:
Non-Hazardous - /

CCT128930 is an ATP-competitive inhibitor of Akt2 (IC50 = 6 nM).{29493} It is selective for Akt over a panel of 47 other kinases, including the related protein kinase A and p70S6K.{29493} CCT128930 blocks the phosphorylation of Akt targets, inhibits proliferation of multiple tumor cell lines in vitro, and prevents the growth of human tumor xenografts in mice.{29493} CCT128930 has been used to elucidate the role of Akt2 in regulating the function of interacting proteins, modulating DNA damage and autophagy in HepG2 hepatoma cells, and cell survival and vasculogenesis in endothelial colony forming cells.{29488,29492,29491}  

 

Available on backorder

SKU: - Category:

Description

An ATP-competitive inhibitor of Akt2 (IC50 = 6 nM); blocks the phosphorylation of Akt targets, inhibits proliferation of multiple tumor cell lines in vitro, and prevents the growth of human tumor xenografts in mice


Formal name: 4-[(4-chlorophenyl)methyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinamine

Synonyms: 

Molecular weight: 341.8

CAS: 885499-61-6

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|PKB/Akt||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Autophagy||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Cancer|DNA Damage and Repair||Research Area|Cell Biology|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy